Table 3

Association between BMI and progression to severe disease in 383 patients with SARS-CoV-2/COVID-19

BMI, kg/m2Number/total number (%)Age-adjusted modelMultivariable model
ORs (95% CIs)P valueORs (95% CIs)P value
Total
 18.5–23.939/203 (19.2)1.001.00
 24–27.936/123 (29.3)1.78 (1.00–3.21)0.051.84 (0.99–3.43)0.05
 28+16/41 (39.0)3.35 (1.47–7.63)0.0043.40 (1.40–8.26)0.007
Men
 18.5–23.920/76 (26.3)1.00
 24–27.923/73 (31.5)1.91 (0.84–4.33)0.121.98 (0.78–5.00)0.15
 28+15/32 (46.9)5.4 (1.93–15.09)0.0015.66 (1.80–17.75)0.003
Women
 18.5–23.919/127 (15.0)1.00
 24–27.913/50 (26)1.76 (0.74–4.22)0.201.64 (0.63–4.29)0.31
 28+1/9 (11.1%)0.58 (0.07–5.24)0.630.70 (0.07–7.20)0.76
  • Adjusted for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, COPD, liver disease, and cancer, and drug used for treatment, as appropriate.